Projected Income Statement: Silicon Laboratories Inc.

Forecast Balance Sheet: Silicon Laboratories Inc.

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027
Net Debt 1 -161 -1,589 -662 -394 -382 -408 -496 -697
Change - -886.96% 58.34% 40.48% 3.05% -6.76% -21.57% -40.52%
Announcement Date 03/02/21 02/02/22 01/02/23 07/02/24 04/02/25 - - -
1USD in Million
Estimates

Cash Flow Forecast: Silicon Laboratories Inc.

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027
CAPEX 1 20.42 28.58 26.52 22.28 11.75 26.51 28.82 32.56
Change - 39.93% -7.18% -16% -47.28% 125.64% 8.71% 12.98%
Free Cash Flow (FCF) 1 115.3 62.62 114.7 -52.63 -25.66 75.3 73.63 123
Change - -45.69% 83.24% -145.87% 51.25% 393.48% -2.21% 67.11%
Announcement Date 03/02/21 02/02/22 01/02/23 07/02/24 04/02/25 - - -
1USD in Million
Estimates

Forecast Financial Ratios: Silicon Laboratories Inc.

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027

Profitability

        
EBITDA Margin (%) 19.31% 17.72% 23.14% 11.61% -9.21% 7.11% 14.56% 17.61%
EBIT Margin (%) 17.31% 15.21% 20.94% 8.33% -13.58% 3.11% 11.04% 14.64%
EBT Margin (%) 1.73% -8.07% 12.35% -1.35% -26.49% -7.55% 0.72% -
Net margin (%) 1.41% 293.73% 8.93% -4.41% -32.69% -8% -0.74% 2.77%
FCF margin (%) 13% 8.69% 11.2% -6.73% -4.39% 9.6% 7.96% 11.49%
FCF / Net Income (%) 920.09% 2.96% 125.54% 152.48% 13.43% -120.11% -1,069% 415.46%

Profitability

        
ROA 7.28% - - 2.99% -4.12% 2.4% 6.69% 10.9%
ROE 11.54% 8.02% 9.4% 4.13% -4.8% 2.87% 8.51% 12.38%

Financial Health

        
Leverage (Debt/EBITDA) - - - - - - - -
Debt / Free cash flow - - - - - - - -

Capital Intensity

        
CAPEX / Current Assets (%) 2.3% 3.96% 2.59% 2.85% 2.01% 3.38% 3.12% 3.04%
CAPEX / EBITDA (%) 11.93% 22.38% 11.19% 24.53% -21.82% 47.52% 21.4% 17.27%
CAPEX / FCF (%) 17.71% 45.63% 23.12% -42.34% -45.79% 35.2% 39.14% 26.46%

Items per share

        
Cash flow per share 1 - - - - -0.4321 2.9 3 4.54
Change - - - - - 771.14% 3.45% 51.33%
Dividend per Share 1 - - - - - - - -
Change - - - - - - - -
Book Value Per Share 1 27.32 57.49 43.91 37.89 33.55 33.12 34.88 37.32
Change - 110.48% -23.62% -13.72% -11.45% -1.29% 5.33% 6.97%
EPS 1 0.28 47.78 2.54 -1.09 -5.93 -1.913 -0.2102 0.8867
Change - 16,964.29% -94.68% -142.91% -444.04% 67.74% 89.02% 521.9%
Nbr of stocks (in thousands) 43,827 40,187 33,283 31,779 32,448 32,853 32,853 32,853
Announcement Date 03/02/21 02/02/22 01/02/23 07/02/24 04/02/25 - - -
1USD
Estimates
2025 *2026 *
P/E ratio -77.7x -708x
PBR 4.49x 4.26x
EV / Sales 5.71x 4.75x
Yield - -
More valuation ratios * Estimated data

EPS & Dividend

Y-o-Y evolution of P/E

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
A
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
148.74USD
Average target price
152.20USD
Spread / Average Target
+2.33%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. SLAB Stock
  4. Financials Silicon Laboratories Inc.